Revvity Signals || Signals One™
Pharma Focus Europe
Get published
magazine-slider-image
Get Latest e-Book

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

Advisory Board

Victor M. Diaz Perez

Victor M. Diaz Perez
Kishore Hotha

Kishore Hotha
Joab Williamson

Joab Williamson
Scott M. Wheelwright

Scott M. Wheelwright
Gustavo Samojeden

Gustavo Samojeden
Juris Hmelnickis

Juris Hmelnickis
Dmitrii Vitalievich Kriuchkov

Dmitrii Vitalievich Kriuchkov
Nigel Cryer FRSC

Nigel Cryer FRSC
Hoda Gamal

Hoda Gamal
Hassan Mostafa Mohamed

Hassan Mostafa Mohamed
Teresa Derbiszewska

Teresa Derbiszewska
Paola Antonini

Paola Antonini

KNOWLEDGE BANK

  • Articles

    Top 5 Pharma Content Formats That Drive Engagement and Leads

    The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...

    Bridging the Biotech–Pharma Innovation Gap Through Strategic Partnerships

    Europe has never lacked ideas Its universities translational institutes and spinout companies consistently generate novel biology from geneediting tools to antibody engineering and mRNA platforms What the continent has struggled with is the journey that follows turning a validated mechanism into an approved reimbursed and reliably manufactured medicine That journey demands capital regulatory fluen...

    7 B2B Pharma Display Ad Strategies That Actually Drive Leads (2026 Guide)

    Theres a quiet frustration most pharma marketers dont say out loud display ads should work better than they do Budgets go in Impressions look fine CTRs are acceptable And yet pipeline barely moves

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Since initial reports from Wuhan China in December and the subsequent declaration of a global pandemic by the WHO in March CoVID has precipitated the greatest health crisis in modern history While exposing fundamental weaknesses in healthcare systems across the globe this tragedy has also been an opportunity for scientists and researchers in different fields to collaborate and produce solutions...

    How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights

    The pharmaceutical industry operates within a complex regulatory framework aimed at ensuring the safety efficacy and quality of medicinal products

    Gene Therapy: Breakthrough Treatments for Rare Diseases

    The idea of gene therapy is radically changing the sphere of medicine with the possibilities to cure the patients with the rare hereditary diseases These diseases which are usually brought about by the alteration of the sequence

TOP ARTICLES

  • 3

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Smriti Sharma Bhatia

    Yousuf Khan

    Kunika Saini

    QSAR modelling has been used extensively as an efficient method in the process of drug development against CoVID-19. The rapid spread and devastating impact of this viral disease across the globe requ...

  • 5

    Gene Therapy: Breakthrough Treatments for Rare Diseases

    Kate Williamson

    As a novel healing technique, gene therapy targets core issues in hereditary diseases. This is another approach where damaged genes are altered or removed; this has a ray of hope in diseases like SCID...

press releases Read more...

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

MacroGenics Inc a clinicalstage biopharmaceutical company focused on developing innovative antibodybased therapeutics for the treatment of cancer today announced that the first patient has been dosed in the Phase study of MGC a firstinclass antibodydrug conjugate

Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy

Legend Biotech Corporation a global leader in cell therapy today announced that the US Food and Drug Administration FDA has cleared the investigational new drug IND application for LB an investigational in vivo CART therapy designed to generate CDCD dualtargeting chimeric antigen receptor T

Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer

Eikon Therapeutics Inc a latestage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs today announced the submission of an Investigational New Drug IND application to the US Food and Drug Administration FDA to evaluate EIK for the t...

Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome

Orvida Pharma a clinicalstage biotechnology company developing first and bestinclass treatments for rare and severe genetic skin diseases today announced that the US Food and Drug Administration FDA has accepted KM ontivatrep the Companys lead oral investigational therapy for Olmsted syndrome

Events Read more...

21 - 23

Oct 2026

Drug Formulation & Drug Delivery 2026

Paris, France

21 - 22

Oct 2026

Advance Clinical Trials and Research 2026

Paris, France

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

26 - 28

Oct 2026

World Orphan Drug Congress

RAI, Amsterdam, Netherlands

27 - 28

Oct 2026

Pharma Manufacturing & Automation Convention 2026

Novotel Hyderabad Airport, Ind...

28 - 30

Oct 2026

BIOPLUS-INTERPHEX KOREA 2026

COEX, Seoul

02 - 04

Nov 2026

Pharma Forum EMEA 2026

Dom Pedro Lisboa Hotel, Lisbon...

LATEST NEWS Read more...

AtomVie Global Radiopharma Announces Strategic Partnership with Jubilant Radiopharma to Strengthen Logistics and Distribution in Clinical Trials

AtomVie Global Radiopharma a global contract developer and manufacturer CDMO for radiopharmaceuticals today announced a strategic partnership with Jubilant DraxImage Inc operating as Jubilant Radiopharma Jubilant Radiopharma to provide logistics approval and lastmile distribution services to support

Transcripta Bio Announces Research Collaboration to Advance Discovery of New ALS Treatments

Transcripta Bio an AIpowered drug discovery company focused on neurological and neuromuscular diseases today announced a research collaboration and licensing agreement with Mayo Clinic centered on amyotrophic lateral sclerosis ALS a fatal neurodegenerative disease with few effective treatments

Insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies

Insitro an AI company unlocking causal human biology to systematically generate highvalue therapeutics to treat grievous illness today announced a worldwide exclusive research collaboration agreement with AstraZeneca to discover novel targets and therapeutics in metabolic dysfunctionassociated steat...

Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors

Vir Biotechnology Inc announced a collaboration and license agreement with Gilead to discover and engineer three novel PROXTEN dualmasked Tcell engager TCE development candidates targeting selected solid tumorassociated antigens Gilead will have an exclusive license to develop and commercialize

Genezen and Galibra Neuroscience Partner to Advance Gene Therapy for SSADH Deficiency Toward First-in-Human Trial

Genezen a gene therapy contract development and manufacturing organization CDMO and Galibra Neuroscience a biotechnology company developing transformative therapies for rare neurological disorders today announced a manufacturing partnership to advance Galibras GAL program an AAVbased gene therapy fo...

Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

Zealand Pharma AS a biotechnology company transforming the future of metabolic health today announced a multitarget strategic collaboration with Generate Biomedicines Inc Under the collaboration the companies intend to design and develop multispecific protein therapeutics

Sartorius - Claim your complimentary Cytokines
Infors HT || Multifors 3
Yokogawa - Why Data Integrity Has Become a Boardroom Issue
Bend Bioscience - The Development-GMP Gap